T Nagar, Chennai, Tamil Nadu
GST No. 33AGQPV7819N1ZD
Approx. Rs 2,500 / PieceGet Latest PriceProduct Details:
|Treatment||Used for the treatment of chronic hepatitis C|
|Dose/Strength (ex. 1 mg or 1 ml)||60|
Natdac (Daclatasvir) is a drug for the treatment of hepatitis C (HCV). it is approved for Hepatitis C genotype 3 infections.
Daclatasvir inhibits the HCV nonstructural protein NS5A. Recent research suggests that it targets two steps of the viral replication process, enabling rapid decline of HCV RNA.
Daclatasvir has been tested in combination regimens with pegylated interferonand ribavirin, as well as with other direct-acting antiviral agents including asunaprevir and sofosbuvir.
Approx. Rs 2,600 / StripGet Latest PriceProduct Details:
|Minimum Order Quantity||84 Strip|
|Treatment||Helps in reducing the weight of obese patients.|
|Product Type||Finished Product|
Product Price :Get Latest PriceProduct Details:
|Packaging Size||5 ml|
|Manufacturer||Zuventus Healthcare Ltd|
|Treatment||Used to delay the premature birth of a baby|
Atosiban ( Inj Tosiban 6.75 mg & 37.5 mg) by Zuventus is an inhibitor of the hormones oxytocin and vasopressin. Atosiban is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labor. Atosiban is a nonapeptide, desamino-oxytocin analogue, and a competitive vasopressin/oxytocin receptor antagonist (VOTra).
Atosiban inhibits the oxytocin-mediated release of inositol trisphosphate from the myometrial cell membrane. As a result, there is reduced release of intracellular, stored calcium from the sarcoplasmic reticulum of myometrial cells, and reduced influx of Ca2+ from the extracellular space through voltage gated channels.
Explore More Products